AI model aims to predict lung fungus relapse before it happens

NCT ID NCT07611838

First seen May 29, 2026 · Last updated Jun 15, 2026 · Updated 4 times

Summary

This study enrolls 300 adults with allergic bronchopulmonary aspergillosis (ABPA) to develop a machine learning model that predicts the risk of relapse within one year. Researchers will analyze patient data and biological markers to create a tool that helps doctors identify high-risk patients and tailor follow-up care. The goal is to improve management and prevent disease recurrence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China, Jinan, Shandong 250014

    RECRUITING

    Jinan, Shandong, 250014, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.